Routledge eBooks
May 9, 2023
Christopher S. Stauffer, Brian T Anderson
2 citations
In this chapter, Chris Stauffer and Brian T. Anderson provide key insights and frameworks derived from their experience facilitating psychedelic-assisted group therapy. Stauffer and Anderson summarize the existing research on this modality and describe the model they have used for preparation, medicine sessions, and integration in a group format. Stauffer and Anderson bring the chapter to a...
May 9, 2023
Karen Peoples
1 citation
In this chapter, Karen Peoples weaves together CJ and psychoanalytic conceptualizations of the “infinite unconscious” to provide a framework for working therapeutically with mystical and NOSC. She offers the reader numerous considerations for the therapist’s access to and containment of unconscious energies, working with the subtle body to facilitate sensory-energetic transformations in...
May 9, 2023
Genesee Herzberg, Jason A. Butler
In this chapter, Genesee Herzberg and Jason Butler weave together relational psychoanalytic theory and technique with contemporary psychedelic research and clinical experience to articulate a model for relational psychedelic therapy. The authors give specific attention to the process of healing the relational wounds of developmental trauma through attunement to the unconscious interpersonal...
May 9, 2023
Jason A. Butler, Evan Sola
1 citation
In this chapter, Jason A. Butler and Evan Sola provide a framework for working with the symbolic images, visions, inchoate sensations, intense emotions, and archetypal energies consistently evoked by psychedelics. The authors weave together Jungian and psychoanalytic theory and technique with psychedelic research and practice to articulate an imaginal model for psychedelic therapy. Using...
The Journal for Nurse Practitioners
May 1, 2023
Amy L Haycraft
Posttraumatic stress disorder (PTSD) treatment options, including the potential use of psychedelic-assisted therapy, are reviewed. Traditional PTSD treatment remains ineffective for many, and includes, trauma focused cognitive behavioral therapy, eye movement desensitization and remodeling, and selective serotonin reuptake inhibitors. Evidence has shown that with further supportive research,...
Physiology
May 1, 2023
Joshua Wyrosdic, Zahra Thirouin, Charles Bourque
Clinical studies have shown that hyponatremia can be induced by the ingestion of the recreational drug MDMA (3,4-Methylenedioxymethamphetamine, ecstasy) when combined with a water intake (Baggot et al., 2016). However, the mechanisms by which MDMA induces hyponatremia is unknown. Hyponatremia is a life-threatening condition that causes rapid swelling of the brain and is commonly encountered...
Healthcare policy = Politiques de sante
May 1, 2023
Sarah Kratina, Christopher Lo, Carol Strike et al.
8 citations
In Canada, the conversation to enable access to therapeutic psychedelics is under way. With recent federal initiatives, Canadians can request access to psychedelic-assisted therapies (PATs) to alleviate enduring and intolerable psychological suffering (EIPS) associated with life-threatening conditions on a case-by-case basis. The resurgence of past research concerning the therapeutic potential...
Healthcare policy = Politiques de sante
May 1, 2023
Daniel Rosenbaum, Sarah Hales, Daniel Z. Buchman
5 citations
We agree with Kratina et al. (2023) that the problem of psychological suffering at the end of life deserves attention from a policy standpoint and that psychedelic therapies show promise in this clinical context. However, we argue the following in this rejoinder: (1) disproportionate attention to psychedelics may overstate the current evidence base, potentially diverting resources away from...
Journal of Psychiatric Research
May 1, 2023
Franklin R. Schneier, Jamie D. Feusner, Michael G. Wheaton et al.
79 citations
Body dysmorphic disorder (BDD) is an often-severe condition in which individuals are preoccupied by misperceptions of their appearance as defective or ugly. Only serotonin reuptake inhibitors and cognitive-behavioral therapy have been demonstrated efficacious in randomized controlled trials. Psilocybin is a psychedelic drug with growing evidence for safety and efficacy in treatment of...
International Journal of Advanced Research
April 30, 2023
Dimple Gupta, Chirag Ambaliya, Aman Ankur et al.
Background:Classical psychedelics are a group of drugs which act as agonists on the serotonin-2A (5-HT2A) receptor. Evidence suggests they may have a uniquely rapid and enduring positive effect on mood. However, marked heterogeneity between methodological designs in this emerging field remains a significant concern. Aims:To determine how differences in the type of psychedelic agent used and the...